Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0008489 (
chorea
)
2,102
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Paroxysmal nonkinesigenic dyskinesia
(
PNKD
) is characterized by attacks of dystonia or
chorea
lasting minutes to hours. Recently, mutations in the myofibrillogenesis regulator 1 gene (MR-1) have been identified in 10 unrelated
PNKD
kindreds. The authors describe a Canadian
PNKD
family who does not have mutations in the MR-1 gene and links to a separate locus at 2q31. This indicates that there are at least two different genes responsible for
PNKD
.
...
PMID:Genetic heterogeneity in paroxysmal nonkinesigenic dyskinesia. 1671 28
The authors present the case of a 26-year-old man with a 10-15-year history of worsening bilateral dystonia and baseline
chorea
occurring up to 20 times per day that was exacerbated by stress and anxiety and was refractory to medical management.
Paroxysmal nonkinesigenic dyskinesia
was diagnosed, which is a rare, hyperkinetic movement disorder that is episodic and does not respond to nonbenzodiazepine antiepileptics. The patient was significantly debilitated by his disease, lived in a group home, and suffered from frequent falls, necessitating the wearing of a protective helmet and face mask at all times. The patient underwent implantation of bilateral deep brain stimulation quadripolar electrodes in the globus pallidus internus with the aid of image-guided stereotactic neurosurgery and microelectrode recording without complication. At his 1-month postoperative follow-up, the patient reported a subjective 90% improvement in his symptoms; the only notable side effect was a slight increased slurring in his baseline dysarthria. Objective reporting and recording forms maintained by the patient's caretakers over the following 18 months suggested a significant and sustained improvement in his overall balance, ambulation, and gross motor function with a substantial decrease in the incidence of reported falls. The authors conclude that pallidal deep brain stimulation may be successfully applied to patients suffering from refractory paroxysmal nonkinesigenic dyskinesia with promising results. This treatment strategy deserves further prospective investigation, clinical consideration, and refinement.
...
PMID:Bilateral deep brain stimulation for treatment of medically refractory paroxysmal nonkinesigenic dyskinesia. 1979 95
Introduction.
Paroxysmal nonkinesigenic dyskinesia
(
PNKD
) consists of episodes of
chorea
, athetosis, or dystonia which are not triggered by movement, with complete remission between episodes. A case of genetically confirmed
PNKD
with simultaneous tremor has not been previously reported. Case Report. The patient is an 86-year-old right-handed female who presented with episodic stiffness, with onset at age 9. Attacks have a prodrome of difficulty in speaking, followed by abnormal sensation in extremities. Episodes consist of dystonia of trunk associated with upper and lower extremity
chorea
. There is complete resolution between attacks except for persistent mild head tremor and action tremor of both extremities. Attack frequency and duration as well as tremor amplitude escalated two and a half years ago, in correlation with development of breast carcinoma. Episodes improved after successful cancer treatment, but higher amplitude tremor persisted. There is an autosomal dominant family history of similar episodes but not tremor. Genetic diagnosis was confirmed via A7V mutation of the myofibrillogenesis regulator (MR-1) gene. Conclusion. Exacerbation due to another medical or psychiatric condition should be considered if there is unexpected deterioration in episode frequency or length.
PNKD
due to MR-1 mutation may exist even in the presence of action tremor.
...
PMID:Paroxysmal nonkinesigenic dyskinesia with tremor. 2417 Nov 25